Teva Has the Firepower for M&A Splash — Market Talk

15:43 EDT – After meeting with new TEVA CEO Erez Vigohman in recent days, JPMorgan says the drug maker aims to do deals in order to grow and has more than $5B available. The company, best known for its generic drugs, will probably do “smaller tuck-in deals” focused on generic technologies,…

Read more…

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s